Human Insulin ELISA KIT (animal serum free)

Staphylococcus aureusis an opportunistic bacterium of the human body and a leading cause of nosocomial infections. Methicillin resistantS. aureus(MRSA) infections involving biofilm lead to higher mortality and morbidity in patients. Biofilm causes serious clinical issues, as it mitigates entry of antimicrobials to reach the etiological agents. It plays an important role in resilient chronic infections which place an unnecessary burden on antibiotics and the associated costs. To combat drug-resistant infection involving biofilm, there is a need to discover potential anti-biofilm agents. In this study, activity of polyphenolic flavonoid glabridin against biofilm formation of methicillin resistant clinical isolates ofS. aureusis being reported for the first time. Crystal violet assay and scanning electron microscopy evidences shows that glabridin prevents formation of cells clusters and attachment of methicillin resistant clinical isolate (MRSA 4423) ofS. aureusto the surface in a dose dependent manner. Gel free proteomic analysis of biofilm matrix by LC-ESI-QTOF confirmed the existence of several proteins known to be involved in cells adhesion. Furthermore, expression analysis of cell surface proteins revealed that glabridin significantly down regulates an abundance of several surface-associated adhesins including fibronectin binding proteins (FnbA, FnbB), serine-aspartate repeat-containing protein D (SdrD), immunoglobulin-binding protein G (Sbi), and other virulence factors which were induced by extracellular glucose in MRSA 4423. In addition, several moonlighting proteins (proteins with multiple functions) such as translation elongation factors (EF-Tu, EF-G), chaperone protein (DnaK), glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and pyruvate kinase (PK) were detected on the cell surface wherein their abundance was inversely proportional to surface-associated adhesins. This study clearly suggests that glabridin prevents biofilm formation inS. aureusthrough modulation of the cell surface proteins.

Quantifications are produced by several disciplinary houses in a myriad of different styles. The concerns about unethical use of algorithms, unintended consequences of metrics, as well as the warning about statistical and mathematical malpractices are all part of a general malaise, symptoms of our tight addiction to quantification. What problems are shared by all these instances of quantification? After reviewing existing concerns about different domains, the present perspective article illustrates the need and the urgency for an encompassing ethics of quantification. The difficulties to discipline the existing regime of numerification are addressed; obstacles and lock-ins are identified. Finally, indications for policies for different actors are suggested.